Journal of Drug Safety and Pharmacovigilance Research

The Journal of Drug Safety and Pharmacovigilance Research is an international, peer-reviewed, open-access journal dedicated to advancing research in drug safety, pharmacovigilance, and medication risk management. The journal provides a platform for researchers, clinicians, pharmacists, regulatory professionals, and healthcare experts to publish high-quality studies that contribute to improving the safety and effectiveness of pharmaceutical therapies.

Drug safety monitoring plays a critical role in healthcare systems by identifying, assessing, and preventing adverse drug reactions and medication-related risks. With the increasing complexity of modern pharmaceuticals and biologic therapies, pharmacovigilance has become essential for ensuring patient safety and improving therapeutic outcomes.

The journal focuses on research that supports better understanding of adverse drug reactions, medication safety practices, post-marketing surveillance, and regulatory strategies used to monitor and improve drug safety worldwide.

Aim and Scope

The Journal of Drug Safety and Pharmacovigilance Research aims to publish high-quality research that enhances understanding of drug safety, pharmacovigilance practices, and risk management strategies associated with pharmaceutical therapies.

The journal welcomes studies that examine adverse drug reactions, medication safety evaluation, regulatory science, and pharmacovigilance systems used to monitor pharmaceutical products. It encourages research that integrates clinical medicine, pharmacy practice, regulatory science, and healthcare systems to improve patient safety and medication management.

The scope also includes research related to post-marketing surveillance, drug risk assessment, medication error prevention, and safety monitoring of new pharmaceutical products and biologics.

Key Topics Covered

The journal welcomes submissions in, but not limited to, the following areas:

• Pharmacovigilance and drug safety monitoring
• Adverse drug reactions and medication-related risks
• Post-marketing surveillance of pharmaceutical products
• Drug safety evaluation and risk management strategies
• Medication errors and patient safety in pharmacotherapy
• Clinical pharmacology and drug safety research
• Regulatory science and pharmaceutical safety policies
• Pharmacovigilance databases and reporting systems
• Drug–drug interactions and medication safety studies
• Safety monitoring of biologics and biosimilars
• Vaccine safety and pharmacovigilance
• Pharmacoeconomics and healthcare outcomes related to drug safety
• Artificial intelligence and data analytics in pharmacovigilance

Article Types Accepted

The journal welcomes the following types of scholarly contributions:

• Original Research Articles
• Review Articles
• Pharmacovigilance Studies
• Clinical Safety Reports
• Case Reports and Case Series related to adverse drug reactions
• Short Communications
• Perspectives and Commentary Articles

Why Publish in This Journal

Publishing in the Journal of Drug Safety and Pharmacovigilance Research offers several advantages:

• International peer-reviewed platform for drug safety research
• Dedicated focus on pharmacovigilance and medication risk management
• Open-access publishing ensuring global visibility
• Rapid and transparent peer-review process
• Opportunity to contribute to improved medication safety and regulatory science
• Permanent digital archiving and global accessibility of published research

Peer Review Process

All manuscripts submitted to the journal undergo a rigorous peer-review process to ensure the quality and scientific integrity of published research. Submissions are first evaluated by the editorial team to confirm their relevance to the journal’s scope and compliance with submission guidelines.

Manuscripts that pass the initial screening are assigned to independent expert reviewers who evaluate the originality, methodological quality, clinical relevance, and clarity of the research. Based on reviewer feedback and editorial evaluation, the editorial board makes the final decision regarding acceptance, revision, or rejection.

Peer Review Process

All manuscripts submitted to the journal undergo a rigorous peer-review process to ensure the quality and scientific integrity of published research. Submissions are first evaluated by the editorial team to confirm their relevance to the journal’s scope and compliance with submission guidelines.

Manuscripts that pass the initial screening are assigned to independent expert reviewers who evaluate the originality, methodological quality, clinical relevance, and clarity of the research. Based on reviewer feedback and editorial evaluation, the editorial board makes the final decision regarding acceptance, revision, or rejection.

Submission Information

Authors interested in submitting their research should ensure that manuscripts comply with the journal’s submission guidelines and formatting requirements. Submissions must represent original work that has not been previously published or simultaneously submitted elsewhere.

Manuscripts may be submitted through the journal’s online submission system or via the editorial office. Authors will receive confirmation upon successful submission and will be notified about the progress of the peer-review process.